| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.0M | +56.9% |
| Cost of Revenue | $4.3M | +11.5% |
| Gross Profit | $2.7M | +330.8% |
| R&D Expense | $974K | -42.7% |
| SG&A Expense | $4.0M | +1.8% |
| Operating Income | -$6.7M | +16.9% |
| Pre-tax Income | -$6.7M | +19.6% |
| Income Tax | -$333K | -825.0% |
| Net Income | -$6.4M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.2M | +4.1% |
| Accounts Receivable | $615K | -68.3% |
| Inventory | $2.9M | +188.8% |
| Current Assets | $6.6M | +9.4% |
| Total Assets | $9.0M | -7.6% |
| Current Liabilities | $3.9M | -7.2% |
| Long-term Debt | $249K | -33.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.1M | +16.2% |
| Capital Expenditures | $7K | -74.1% |
| Investing Cash Flow | -$7K | +99.3% |
| Financing Cash Flow | $6.1M | +9255.2% |
| Free Cash Flow | -$6.1M | +16.5% |
| +23.2% |
| EPS (Basic) | -$2.50 | +66.5% |
| EPS (Diluted) | -$2.50 | +66.5% |
| Total Liabilities |
| $4.3M |
| -18.0% |
| Stockholders' Equity | $4.7M | +4.4% |